[go: up one dir, main page]

AU2002336032A1 - Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions - Google Patents

Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions

Info

Publication number
AU2002336032A1
AU2002336032A1 AU2002336032A AU2002336032A AU2002336032A1 AU 2002336032 A1 AU2002336032 A1 AU 2002336032A1 AU 2002336032 A AU2002336032 A AU 2002336032A AU 2002336032 A AU2002336032 A AU 2002336032A AU 2002336032 A1 AU2002336032 A1 AU 2002336032A1
Authority
AU
Australia
Prior art keywords
hydrates
hydrophilic
pharmaceutical compositions
amlodipine salts
amlodipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002336032A
Other languages
English (en)
Inventor
Xitian Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002336032A1 publication Critical patent/AU2002336032A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002336032A 2001-11-22 2002-10-18 Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions Abandoned AU2002336032A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB011400277A CN1152013C (zh) 2001-11-22 2001-11-22 一类左旋氨氯地平盐的水合物及其制剂
CN01140027.7 2001-11-22
PCT/CN2002/000730 WO2003043989A1 (fr) 2001-11-22 2002-10-18 Sels hydrophiles de (s)-amlodipine ou leurs hydrates et compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
AU2002336032A1 true AU2002336032A1 (en) 2003-06-10

Family

ID=4675599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002336032A Abandoned AU2002336032A1 (en) 2001-11-22 2002-10-18 Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions

Country Status (5)

Country Link
EP (1) EP1458681A4 (fr)
KR (1) KR20050037498A (fr)
CN (1) CN1152013C (fr)
AU (1) AU2002336032A1 (fr)
WO (1) WO2003043989A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279492B2 (en) 2002-09-11 2007-10-09 Hanlim Pharmaceutical Co., Ltd. S-(−)-amlodipine nicotinate and process for the preparation thereof
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use
WO2005097191A2 (fr) * 2004-04-04 2005-10-20 Sepracor Inc. Combinaisons comprenant de la (s)-amlodipine et un inhibiteur de la hmg-coa reductase ou un inhibiteur de l'absorption de cholesterol ou les deux a la fois et methodes permettant de reduire l'hypertension
WO2005099699A1 (fr) * 2004-04-07 2005-10-27 Sepracor Inc. Combinaison de (s)-amlodipine et d'un betabloquant, et procedes pour la reduction de l'hypertension
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (ｓ)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
KR100830003B1 (ko) * 2006-10-31 2008-05-15 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
KR100843400B1 (ko) * 2006-11-14 2008-07-04 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 말레익산 염 무수물 및 이의제조방법
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
KR100843401B1 (ko) * 2006-12-04 2008-07-04 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 캠실레이트 무수물 및 이의제조방법
KR100840069B1 (ko) * 2007-01-23 2008-06-20 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 오로테이트 무수물 및 이의제조방법
CN105111137B (zh) * 2015-08-21 2016-04-27 薛传校 苯磺酸左旋氨氯地平晶体、其制备方法和应用
CN111689894B (zh) * 2019-03-13 2023-05-02 鲁南制药集团股份有限公司 一种苯磺酸左旋氨氯地平晶型
CN112110850B (zh) * 2019-06-20 2023-05-02 鲁南制药集团股份有限公司 一种苯磺酸左旋氨氯地平新晶型
CN113041244B (zh) 2019-11-08 2022-06-21 施慧达药业集团(吉林)有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法
CN112704667A (zh) * 2021-02-24 2021-04-27 施慧达药业集团(吉林)有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2233974A (en) * 1989-07-22 1991-01-23 Pfizer Ltd Dihydropyridine antiinflammatory agent
WO1993010779A1 (fr) * 1991-11-26 1993-06-10 Sepracor, Inc. Procedes et compositions destines a traiter l'hypertension, l'angine de poitrine et d'autres troubles a l'aide de (-)amlodipine optiquement pure
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
GB9317773D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
HN2000000050A (es) * 1999-05-27 2001-02-02 Pfizer Prod Inc Sal mutua de amlodipino y atorvastatina
CN1100038C (zh) * 2000-02-21 2003-01-29 张喜田 氨氯地平对映体的拆分
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
WO2004096770A1 (fr) * 2003-04-25 2004-11-11 Cipla Limited Procede de preparation de mesylate d'amlodipine monohydrate

Also Published As

Publication number Publication date
EP1458681A4 (fr) 2005-04-27
CN1152013C (zh) 2004-06-02
EP1458681A1 (fr) 2004-09-22
CN1355162A (zh) 2002-06-26
KR20050037498A (ko) 2005-04-22
WO2003043989A1 (fr) 2003-05-30

Similar Documents

Publication Publication Date Title
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2002335536A1 (en) Pyrimidine compound and medicinal composition thereof
AU2002313236A1 (en) Medicinal compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2002336032A1 (en) Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions
AU2002258221A1 (en) Medicinal composition
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002252981A1 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
AU2003257780A1 (en) Pharmaceutical compositions containing polydatin or its salts and their application
HK1071887A (en) Hydrophilic (s)-amlodipine salts or their hydrates and pharmaceutical compositions
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002354460A1 (en) Medicinal composition
AU2002333942A1 (en) Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same
AUPR529701A0 (en) Pharmaceutical composition
AU2001241194A1 (en) Nitroethenamine derivatives or salts thereof and pharmaceutical compositions containing the derivatives or the salts
AU2002346223A1 (en) Medicinal compositions
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002100921A4 (en) Pharmaceutical composition
AU2002307679A1 (en) Pharmaceutical compositions comprising chelidonine or derivatives thereof
AU2002331590A1 (en) Composition comprising phosphonium salts and their use
AU2002324359A1 (en) Compositions containing itraconazole and their preparation methods
AU2002247745B2 (en) Pharmaceutical salts
AU2002256154A1 (en) Aminobenzopyran derivatives and compositions
AU2002339723A1 (en) Pharmaceutical composition comprising chito-oligomers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase